Patient compliance and the conduct and interpretation of therapeutic trials

Low patient compliance with prescribed treatments is a very common problem in clinical care and can seriously distort the generalizability and validity of controlled clinical trials. Aside from undermining the benefit of any treatment, noncompliance is often, but unpredictably, a marker for adverse patient outcomes independent of any treatment effect. The proper management of compliance in therapeutic trials depends in part on the objectives of …